Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Cyclosporin A À¯µµ Ä¡ÀºÁõ½Ä¿¡¼­ DD-PCRÀ» ÀÌ¿ëÇÑ À¯ÀüÀÚ °Ë»ö

Gene Screening in Cyclosporin A Induced Gingival Overgrowth Using Differential Display PCR

´ëÇѱ¸°­¾Ç¾È¸éº´¸®ÇÐȸÁö 2002³â 26±Ç 4È£ p.281 ~ 290
¼Ò¼Ó »ó¼¼Á¤º¸
±è¿ÁÁØ/Kim OJ ÃÖÈ«¶õ/Á¤Áö¿¬/°íÁ¤ÅÂ/¹ÚÁ¾ÅÂ/Á¤º´Ã¶/¹®Á¤¼±/±è¿øÀç/±èÇöÁø/±è¼±Çå/Choi HR/Jung JY/Koh JT/Park JT/Jeong BC/Moon JS/Kim WJ/Kim HJ/Kim SH

Abstract


Cyclosporin A(CsA) is a polypeptide composed of 11 amino acied used as a widely spread immunosuppressive drug to prevent transplant rejection and also in the treatment of various pathological condition. The CsA treatment may cause various side effects including gingival overgrowth. However, its molecular events are not well understood.
Twenty male Sprague-Dawley rats weighing about 150g were injected by CsA at a concentration of 10 §·/§¸ for 8 weeks. Gingival overgrowth at lower incisors was confirmed by histologic findings. To investigate the CsA role in gingival overgrowth, differential display(DD)-PCR was carried out. One of the under-expressed genes in CsA-treated rats was a VDAC2, which is located in the outer membrane of mitochondria.
Considering the role of VDAC2, as the gate for mitochondria-dependent apoptotic molecules, anti-apoptotic changes are suggested in CsA-induced gingival overgrowth.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI